SNS Laboratories Latest Annual Report, Balance Sheet and Financials

Particulars

2018

2017

(1)   ASSETS

Non-current assets

-

-

(a)  Property, Plant and Equipment

(b)  Capital work-in-progress

(c)  Investment Property

(d)  Goodwill

-

-

(e)  Other Intangible assets

-

-

(f)  Intangible assets under development

-

-

(g)   Biological Assets other than bearer plants

-

-

(h)  Financial Assets

-

-

(i)  Investments

-

-

(ii)  Trade receivables

-

-

(iii)  Loans

(iv)  Others (to be specified)

-

-

(i)  Deferred tax assets (net)

-

-

(j)  Other non-current assets

-

-

(2)   Current assets

-

-

(a)  Inventories

-

-

(b)  Financial Assets

-

-

(i)  Investments

-

-

(ii)  Trade receivables

-

-

(iii)  Cash and cash equivalents

-

16

(iv)  Bank balances other than (iii) above

189

198

(v)  Loans

6

125

(vi)  Others (to be specified)

-

-

(c)  Current Tax Assets (Net)

-

-

(d)  Other current assets

-

-

-

-

Total Assets

195

339

EQUITY AND LIABILITIES

Equity

(a)  Equity Share Capital

28,625

28,625

(b)  Other Equity

-29,105

-28,648

LIABILITIES

Non-current liabilities

(a)  Financial Liabilities

(i)  Borrowings

(ii)  Trade payables

(iii)  Other financial liabilities (other than those specified in item (b), to  be specified)

135 

135 

(b)  Provisions

(c)  Deferred tax liabilities (Net)

-

-

(d)  Other non-current liabilities

-

-

Current liabilities

(a)  Financial Liabilities

-

-

(i)  Borrowings

257

200

(ii)  Trade payables

-

-

(iii)    Other financial liabilities (other than those specified in item (c)

283

27

(b)  Other current liabilities

(c)  Provisions

-

-

(d)  Current Tax Liabilities (Net)

Total Equity and Liabilities

195

339

Particulars

2018

2017

Income

Revenue From Operations

Other Income

Total Income (I+II)

-

-

EXPENSES

Stock-in -Trade and work-in-progress

Employee benefits expense

-

-

Finance costs

Depreciation and amortization expense

Other expenses

457

385

Total expenses

457

385

Profit/(loss)   before   exceptional   items and tax

Exceptional Items

Profit/(loss) before tax

-457

-385

Tax expense:

(1) Current tax

(2) Deferred tax

Profit (Loss) for the period from continuing operations

-457

-385

Profit/(loss) from discontinued Operations

Tax expense of discontinued operations

Profit/(loss) from Discontinued operations

Profit/(loss) for the period

-457

-385

Other Comprehensive Income

A (i) Items that will not be reclassified to profit or loss

(ii) Income tax relating to items that will not be reclassified to profit or loss

B (i) Items that will be reclassified to profit or loss

(ii) Income tax relating to items that will be reclassified to profit or loss

Total Comprehensive Income for the period (Comprising Profit (Loss) and Other Comprehensive Income

Earnings per equity share

(1) Basic

-

-

(2) Diluted

-

-

Particulars

2018

2017

Cash flows from operating activities

Profit before taxation Adjustments for:

-4.57

-3.85

Depreciation

Working capital changes:

(Increase) / Decrease in trade and other receivables

-0.16

-0.16

Increase / (Decrease) in Current Liabilities

2.57

3.11

Cash generated from operations

Interest paid

Income taxes paid

0.25

Dividends paid

Net cash from operating activities

-1.84

-1.15

Cash flows from investing activities

-

-

Business acquisitions, net of cash acquired

Proceeds from sale of equipment

Net cash used in investing activities

-

-

Cash flows from financing activities

-

-

Proceeds from issue of share capital

Proceeds from long-term borrowings

0.57

Net cash used in financing activities

0.57

-

Net increase in cash and cash equivalents

-1.28

-1.15

Cash and cash equivalents at beginning of period

3.23

4.38

Cash and cash equivalents at end of period

1.95

3.23